Blog
Articles, guides, and regulatory updates from our community.
AllClinical ApplicationsLongevityPeptide BasicsProvider ResourcesResearch & ScienceSafety & RegulationWeight Management
503A503BAnti-AgingBPC-157BremelanotideCJC-1295CircadianComplianceCompoundingCopper PeptideDSIPEpitalonEvidence ReviewFDAFDA ApprovedGHK-CuGIGLP-1Getting StartedGrowth HormoneGut HealthHealingHumaninIBSImmune SupportImmunologyIpamorelinKPVLarazotideLongevityMOTS-cMelanocortinMitochondriaNAD+ObesityPT-141Patient EducationPeptide BasicsPharmacyProvider GuideQualityRecoveryRegulationResearchSafetySemaglutideSexual HealthSide EffectsSkin HealthSleepTesamorelinThymosin Alpha-1TirzepatideWeight Management
Showing 2 articles tagged semaglutideClear filters
Mar 5, 202611 min read
Weight Management
How Peptide Therapy Is Transforming Weight Management
The GLP-1 revolution has rewritten the rules of obesity treatment. How incretin-based peptide therapies achieve what diet and exercise alone cannot — and what comes next.
Weight ManagementGLP-1Obesity+2
By Peptide Association Editorial Team
Feb 3, 202612 min read
Clinical Applications
Semaglutide vs Tirzepatide: Comparing GLP-1 Therapies
A head-to-head comparison of the two leading GLP-1 receptor agonists — mechanisms of action, clinical trial data, side effects, and practical considerations for providers and patients.
GLP-1Weight ManagementSemaglutide+1
By Peptide Association Editorial Team